Interferon-β directly influences monocyte infiltration into the central nervous system

被引:141
作者
Floris, S
Ruuls, SR
Wierinckx, A
van der Pol, SMA
Döpp, E
van der Meide, PH
Dijkstra, CD
De Vries, HE
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, NL-1081 BT Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Med Pharmacol, NL-1081 BT Amsterdam, Netherlands
[3] Univ Utrecht, U Cytech, NL-3584 CJ Utrecht, Netherlands
关键词
adhesion molecules; multiple sclerosis; cerebral endothelium; interferon-beta; monocytes; experimental allergic encephalomyelitis;
D O I
10.1016/S0165-5728(02)00098-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interferon-beta (IFN-beta) has beneficial effects on the clinical symptoms of multiple sclerosis (MS) patients, but its exact mechanism of action is yet unknown. We here suggest that IFN-beta directly modulates inflammatory events at the level of cerebral endothelium. IFN-beta treatment resulted in a marked reduction of perivascular infiltrates in acute experimental allergic encephalomyelitis (EAE), the rat model for MS, which was coupled to a major decrease in the expression of the adhesion molecules ICAM-1 and VCAM-1 on brain capillaries. In vitro, IFN-beta reduced the mRNA levels and protein expression of adhesion molecules of brain endothelial cell cultures and diminished monocyte transendothelial migration. Monocyte adhesion and subsequent migration was found to be predominantly regulated by VCAM-1. These data indicate that IFN-beta exerts direct antiinflammatory effects on brain endothelial cells thereby contributing to reduced lesion formation as observed in MS patients. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:69 / 79
页数:11
相关论文
共 50 条
[1]   The cellular immunology of multiple sclerosis [J].
Al-Omaishi, J ;
Bashir, R ;
Gendelman, HE .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (04) :444-452
[2]  
Barone C M, 1993, J Craniofac Surg, V4, P177, DOI 10.1097/00001665-199307000-00013
[3]   VASCULAR CELL-ADHESION MOLECULE-1 MODULATION BY TUMOR-NECROSIS-FACTOR IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS [J].
BARTEN, DM ;
RUDDLE, NH .
JOURNAL OF NEUROIMMUNOLOGY, 1994, 51 (02) :123-133
[4]  
BEEKHUIZEN H, 1993, J IMMUNOL, V150, P950
[5]   Antibodies to CD44 and integrin α4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment [J].
Brocke, S ;
Piercy, C ;
Steinman, L ;
Weissman, IL ;
Veromaa, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6896-6901
[6]  
Bruck W, 1996, IMMUNOBIOLOGY, V195, P588
[7]   MONOCYTE-MACROPHAGE DIFFERENTIATION IN EARLY MULTIPLE-SCLEROSIS LESIONS [J].
BRUCK, W ;
PORADA, P ;
POSER, S ;
RIECKMANN, P ;
HANEFELD, F ;
KRETZSCHMAR, HA ;
LASSMANN, H .
ANNALS OF NEUROLOGY, 1995, 38 (05) :788-796
[8]   T lymphocytes conditioned with Interferon β induce membrane and soluble VCAM on human brain endothelial cells [J].
Calabresi, PA ;
Prat, A ;
Biernacki, K ;
Rollins, J ;
Antel, JP .
JOURNAL OF NEUROIMMUNOLOGY, 2001, 115 (1-2) :161-167
[9]   THE ADHESION MOLECULE AND CYTOKINE PROFILE OF MULTIPLE-SCLEROSIS LESIONS [J].
CANNELLA, B ;
RAINE, CS .
ANNALS OF NEUROLOGY, 1995, 37 (04) :424-435
[10]   Effects of beta-IFN-1b treatment in MS patients on adhesion between PBMNCs, HUVECs and MS-HBECs: an in vivo and in vitro study [J].
Corsini, E ;
Gelati, M ;
Dufour, A ;
Massa, G ;
Nespolo, A ;
Ciusani, E ;
Milanese, C ;
LaMantia, L ;
Salmaggi, A .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 79 (01) :76-83